To treat obesity and related diseases, considerable effort has gone into developing strategies to convert white adipocytes into thermogenic brown-like adipocytes (‘browning’). The purpose of this study was to identify the most efficient signal control for browning.
To identify the most efficient signal control for browning, we examined rat stromal vascular fraction cells. In addition, physiological changes consequent to signal control were examined in vivo using lean and diet-induced obese (DIO) C57BL/6J mice.
Combined treatment with the peroxisome proliferator-activated receptor γ (PPARγ) agonist rosiglitazone, the SMAD3 inhibitor SIS3 and the adrenergic receptor agonist noradrenaline (norepinephrine) synergistically induced Ucp1, Fgf21 and Cited1 expression, triggering brown adipogenesis. Synergistic induction of Ucp1 by the three agents was negatively regulated by forkhead box O (FOXO)3 via the inhibition of PPARγ-dependent gene transcription. Moreover, the administration of rosiglitazone, SIS3 and the selective β3 adrenergic receptor agonist CL316,243 to DIO mice reduced the amount of body-fat deposits (body weight from day 0 to 14, 12.3% reduction), concomitant with morphological changes in white adipose tissue, an increase in mitochondrial biosynthesis and a marked induction of uncoupling protein 1 (UCP1). Furthermore, administration of the three agents significantly increased serum adiponectin levels (mean 65.56 μg/ml with the three agents vs 20.79 μg/ml in control mice, p < 0.05) and improved glucose and lipid tolerance.
These results suggest that the combined regulation of PPARγ, SMAD and the adrenergic receptor signalling pathway synergistically induces brown adipogenesis and may serve as an effective strategy to treat obesity and related diseases, including type 2 diabetes.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Brown adipose tissue
Forkhead box O
Inguinal white adipose tissue
- MYF 5 :
Myogenic factor 5
- nTZDpa :
Non-thiazolidinedione partial agonist of peroxisome proliferator-activated receptor γ
Peroxisome proliferator-activated receptor γ coactivator 1α
Peroxisome proliferator-activated receptor γ
PRD1-BF1-RIZ1 homologous domain containing 16
Small interfering RNA
Specific inhibitor of SMAD3
Stromal vascular fraction
Uncoupling protein 1
Bray GA, Bellanger T (2006) Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29(1):109–117. https://doi.org/10.1385/ENDO:29:1:109
Cedikova M, Kripnerová M, Dvorakova J, et al (2016) Mitochondria in white, brown, and beige adipocytes. Stem Cells Int 6067349. https://doi.org/10.1155/2016/6067349
Klingenberg M (1999) Uncoupling protein—a useful energy dissipator. J Bioenerg Biomembr 31(5):419–430. https://doi.org/10.1023/A:1005440221914
Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84(1):277–359. https://doi.org/10.1152/physrev.00015.2003
Feldmann HM, Golozoubova V, Cannon B, Nedergaard J (2009) UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 9(2):203–209. https://doi.org/10.1016/j.cmet.2008.12.014
Stanford KI, Middelbeek RJ, Townsend KL et al (2013) Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest 123(1):215–223. https://doi.org/10.1172/JCI62308
Heaton JM (1972) The distribution of brown adipose tissue in the human. J Anat 112(pt 1):35–39
Saito M, Okamatsu-Ogura Y, Matsushita M et al (2009) High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58(7):1526–1531. https://doi.org/10.2337/db09-0530
Virtanen KA, Lidell ME, Orava J et al (2009) Functional brown adipose tissue in healthy adults. N Engl J Med 360(15):1518–1525. https://doi.org/10.1056/NEJMoa0808949
Yoneshiro T, Aita S, Matsushita M et al (2011) Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity (Silver Spring) 19(9):1755–1760. https://doi.org/10.1038/oby.2011.125
Yoneshiro T, Aita S, Matsushita M et al (2011) Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity (Silver Spring) 19(1):13–16. https://doi.org/10.1038/oby.2010.105
van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM et al (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360(15):1500–1508. https://doi.org/10.1056/NEJMoa0808718
Wu J, Boström P, Sparks LM et al (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150(2):366–376. https://doi.org/10.1016/j.cell.2012.05.016
Harms M, Seale P (2013) Brown and beige fat: development, function and therapeutic potential. Nat Med 19(10):1252–1263. https://doi.org/10.1038/nm.3361
Sharp LZ, Shinoda K, Ohno H et al (2012) Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS One 7(11):e49452. https://doi.org/10.1371/journal.pone.0049452
Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J (2010) Chronic peroxisome proliferator-activated receptor γ (PPARγ) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 285(10):7153–7164. https://doi.org/10.1074/jbc.M109.053942
Rong JX, Qiu Y, Hansen MK et al (2007) Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 56(7):1751–1760. https://doi.org/10.2337/db06-1135
Kajimura S, Seale P, Tomaru T et al (2008) Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev 22(10):1397–1409. https://doi.org/10.1101/gad.1666108
Yoshida H, Kanamori Y, Asano H et al (2013) Regulation of brown adipogenesis by the Tgf-β family: involvement of Srebp1c in Tgf-β- and activin-induced inhibition of adipogenesis. Biochim Biophys Acta 1830(11):5027–5035. https://doi.org/10.1016/j.bbagen.2013.06.036
Tseng YH, Kokkotou E, Schulz TJ et al (2008) New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454(7207):1000–1004. https://doi.org/10.1038/nature07221
Yadav H, Quijano C, Kamaraju AK et al (2011) Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling. Cell Metab 14(1):67–79. https://doi.org/10.1016/j.cmet.2011.04.013
Park JH, Hur W, Lee SB (2015) Intricate transcriptional networks of classical brown and beige fat cells. Front Endocrinol (Lausanne) 6:124. https://doi.org/10.3389/fendo.2015.00124
Song NJ, Chang SH, Li DY, Villanueva CJ, Park KW (2017) Induction of thermogenic adipocytes: molecular targets and thermogenic small molecules. Exp Mol Med 49(7):e353. https://doi.org/10.1038/emm.2017.70
Wilding J (2006) Thiazolidinediones, insulin resistance and obesity: finding a balance. Int J Clin Pract 60(10):1272–1280. https://doi.org/10.1111/j.1742-1241.2006.01128.x
Péronnet F, Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16(1):23–29
Shimotoyodome A, Fukuoka D, Suzuki J et al (2009) Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice. Endocrinology 150(5):2118–2126. https://doi.org/10.1210/en.2008-1162
Murase T, Yokoi Y, Misawa K et al (2012) Coffee polyphenols modulate whole-body substrate oxidation and suppress postprandial hyperglycaemia, hyperinsulinaemia and hyperlipidaemia. Br J Nutr 107(12):1757–1765. https://doi.org/10.1017/S0007114511005083
Onuma H, Vender Kooi BT, Boustead JN, Oeser JK, O’Brien RM (2006) Correlation between FOXO1 (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin. Mol Endocrinol 20(11):2831–2847. https://doi.org/10.1210/me.2006-0085
Munekata K, Sakamoto K (2009) Forkhead transcription factor Foxo1 is essential for adipocyte differentiation. In Vitro Cell Dev Biol Anim 45(10):642–651. https://doi.org/10.1007/s11626-009-9230-5
MacPherson RE, Castellani L, Beaudoin MS, Wright DC (2014) Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice. Am J Physiol Endocrinol Metab 307(7):E563–E570. https://doi.org/10.1152/ajpendo.00287.2014
Ohno H, Shinoda K, Spiegelman BM, Kajimura S (2012) PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 15(3):395–404. https://doi.org/10.1016/j.cmet.2012.01.019
Feng XH, Derynck R (2005) Specificity and versatility in TGF-β signaling through SMADs. Annu Rev Cell Dev Biol 21(1):659–693. https://doi.org/10.1146/annurev.cellbio.21.022404.142018
Fan W, Imamura T, Sonoda N et al (2009) FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J Biol Chem 284(18):12188–12197. https://doi.org/10.1074/jbc.M808915200
Tzivion G, Dobson M, Ramakrishnan G (2011) FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 1813(11):1938–1945. https://doi.org/10.1016/j.bbamcr.2011.06.002
Nakae J, Oki M, Cao Y (2008) The FoxO transcription factors and metabolic regulation. FEBS Lett 582(1):54–67. https://doi.org/10.1016/j.febslet.2007.11.025
Ventura-Clapier R, Garnier A, Veksler V (2008) Transcriptional control of mitochondrial biogenesis: the central role of PGC-1α. Cardiovasc Res 79(2):208–217. https://doi.org/10.1093/cvr/cvn098
Altshuler-Keylin S, Shinoda K, Hasegawa Y et al (2016) Beige adipocyte maintenance is regulated by autophagy-induced mitochondrial clearance. Cell Metab 24(3):402–419. https://doi.org/10.1016/j.cmet.2016.08.002
Webb AE, Brunet A (2014) FOXO transcription factors: key regulators of cellular quality control. Trends Biochem Sci 39(4):159–169. https://doi.org/10.1016/j.tibs.2014.02.003
Furuyama T, Nakazawa T, Nakano I, Mori N (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349(pt 2):629–634. https://doi.org/10.1042/bj3490629
Bartelt A, Bruns OT, Reimer R et al (2011) Brown adipose tissue activity controls triglyceride clearance. Nat Med 17(2):200–205. https://doi.org/10.1038/nm.2297
Bartelt A, Widenmaier SB, Schlein C et al (2018) Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity. Nat Med 24(3):292–303. https://doi.org/10.1038/nm.4481
Ruan H, Dong LQ (2016) Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol 8(2):101–109. https://doi.org/10.1093/jmcb/mjw014
Zhu Y, Richardson JA, Parada LF, Graff JM (1998) Smad3 mutant mice develop metastatic colorectal cancer. Cell 94(6):703–714. https://doi.org/10.1016/S0092-8674(00)81730-4
We thank our colleagues in the Biological Science Laboratories, Kao Corporation, for the helpful discussions.
This work was supported financially by Kao Corporation. The study sponsor was not involved in the design of the study; the collection, analysis or interpretation of data; writing the report; or the decision to submit the report for publication.
The authors declare that there is no duality of interest associated with this manuscript.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Matsumoto, T., Kiuchi, S. & Murase, T. Synergistic activation of thermogenic adipocytes by a combination of PPARγ activation, SMAD3 inhibition and adrenergic receptor activation ameliorates metabolic abnormalities in rodents. Diabetologia 62, 1915–1927 (2019). https://doi.org/10.1007/s00125-019-4938-6
- PPARγ agonist